, Tracking Stock Market Picks
Enter Symbol:
Biovail Corporation (BVF) [hlAlert]

up 2,336.72 %

Biovail Corporation (BVF) rated Buy with price target $14 by Canaccord Adams

Posted on: Wednesday,  Sep 17, 2008  11:25 AM ET by Canaccord Adams

Canaccord Adams rated Buy Valeant Pharmaceuticals International Inc (NYSE: VRX) on 09/17/2008, when the stock price was $9.64.
Since then, Valeant Pharmaceuticals International Inc has gained 2336.72% as of 01/06/2016's recent price of $234.90.
If you would have followed this Canaccord Adams's recommendation on VRX, you would have gained 2336.72% of your investment in 2667 days.

Biovail Corporation (Biovail) is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company is engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The Company has various research and development, clinical research, manufacturing and commercial operations located in Barbados, Canada, the United States and Puerto Rico. Its main therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease. The primary markets for its products are the United States and Canada. On September 16, 2008, Biovail acquired Prestwick Pharmaceuticals, Inc.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy